nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—Bromfenac—Balsalazide—Crohn's disease	0.202	1	CrCrCtD
Diclofenac—CXCL8—Crohn's disease	0.126	0.645	CbGaD
Diclofenac—migraine—Prednisone—Crohn's disease	0.119	0.508	CpDpCtD
Diclofenac—osteoarthritis—Prednisone—Crohn's disease	0.115	0.492	CpDpCtD
Diclofenac—ALOX5—Balsalazide—Crohn's disease	0.0697	0.256	CbGbCtD
Diclofenac—ALOX5—Mesalazine—Crohn's disease	0.0557	0.205	CbGbCtD
Diclofenac—PTGS2—Crohn's disease	0.0367	0.188	CbGaD
Diclofenac—ALB—Crohn's disease	0.0327	0.168	CbGaD
Diclofenac—ALOX5—Sulfasalazine—Crohn's disease	0.0311	0.115	CbGbCtD
Diclofenac—PTGS2—Balsalazide—Crohn's disease	0.0186	0.0682	CbGbCtD
Diclofenac—ABCC4—Mercaptopurine—Crohn's disease	0.0173	0.0636	CbGbCtD
Diclofenac—PTGS1—Balsalazide—Crohn's disease	0.0157	0.0576	CbGbCtD
Diclofenac—PTGS2—Mesalazine—Crohn's disease	0.0148	0.0545	CbGbCtD
Diclofenac—PTGS1—Mesalazine—Crohn's disease	0.0125	0.0461	CbGbCtD
Diclofenac—SLC22A8—Mercaptopurine—Crohn's disease	0.0108	0.0397	CbGbCtD
Diclofenac—PTGS2—Sulfasalazine—Crohn's disease	0.00829	0.0305	CbGbCtD
Diclofenac—PTGS1—Sulfasalazine—Crohn's disease	0.007	0.0257	CbGbCtD
Diclofenac—ALB—Prednisone—Crohn's disease	0.00418	0.0154	CbGbCtD
Diclofenac—CYP2C19—Prednisone—Crohn's disease	0.00271	0.00996	CbGbCtD
Diclofenac—ABCB1—Prednisone—Crohn's disease	0.00219	0.00804	CbGbCtD
Diclofenac—CYP3A4—Prednisone—Crohn's disease	0.00131	0.00482	CbGbCtD
Diclofenac—PLA2G2A—mouth—Crohn's disease	0.00076	0.0636	CbGeAlD
Diclofenac—CXCR1—lymph node—Crohn's disease	0.000536	0.0449	CbGeAlD
Diclofenac—PLA2G2A—epithelium—Crohn's disease	0.000442	0.037	CbGeAlD
Diclofenac—Clonidine—SLC22A4—Crohn's disease	0.000436	0.295	CrCbGaD
Diclofenac—PLA2G2A—smooth muscle tissue—Crohn's disease	0.000426	0.0357	CbGeAlD
Diclofenac—CXCL8—smooth muscle tissue—Crohn's disease	0.000422	0.0353	CbGeAlD
Diclofenac—ALB—gall bladder—Crohn's disease	0.000412	0.0345	CbGeAlD
Diclofenac—PLA2G2A—mammalian vulva—Crohn's disease	0.000384	0.0321	CbGeAlD
Diclofenac—CYP2C18—mammalian vulva—Crohn's disease	0.00035	0.0293	CbGeAlD
Diclofenac—PLA2G2A—lymphoid tissue—Crohn's disease	0.000341	0.0285	CbGeAlD
Diclofenac—PLA2G2A—digestive system—Crohn's disease	0.000336	0.0282	CbGeAlD
Diclofenac—Clonidine—SLC22A5—Crohn's disease	0.000328	0.222	CrCbGaD
Diclofenac—ASIC1—lymph node—Crohn's disease	0.000319	0.0267	CbGeAlD
Diclofenac—CYP2C18—digestive system—Crohn's disease	0.000307	0.0257	CbGeAlD
Diclofenac—ALOX5—smooth muscle tissue—Crohn's disease	0.000291	0.0244	CbGeAlD
Diclofenac—UGT2B7—digestive system—Crohn's disease	0.000283	0.0237	CbGeAlD
Diclofenac—SLC22A11—digestive system—Crohn's disease	0.000276	0.0231	CbGeAlD
Diclofenac—TTR—lymphoid tissue—Crohn's disease	0.000257	0.0215	CbGeAlD
Diclofenac—TTR—digestive system—Crohn's disease	0.000254	0.0213	CbGeAlD
Diclofenac—UGT1A1—digestive system—Crohn's disease	0.000241	0.0201	CbGeAlD
Diclofenac—CYP1A1—mouth—Crohn's disease	0.000238	0.0199	CbGeAlD
Diclofenac—ALOX5—lymphoid tissue—Crohn's disease	0.000233	0.0195	CbGeAlD
Diclofenac—ALOX5—digestive system—Crohn's disease	0.00023	0.0193	CbGeAlD
Diclofenac—PTGS2—gall bladder—Crohn's disease	0.000224	0.0188	CbGeAlD
Diclofenac—PTGS2—mouth—Crohn's disease	0.000199	0.0167	CbGeAlD
Diclofenac—PLA2G2A—lymph node—Crohn's disease	0.000192	0.0161	CbGeAlD
Diclofenac—CXCL8—lymph node—Crohn's disease	0.00019	0.0159	CbGeAlD
Diclofenac—Bromfenac—PTGS2—Crohn's disease	0.000186	0.126	CrCbGaD
Diclofenac—SLCO1C1—lymph node—Crohn's disease	0.000162	0.0136	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—Crohn's disease	0.000158	0.107	CrCbGaD
Diclofenac—ABCC4—digestive system—Crohn's disease	0.000157	0.0131	CbGeAlD
Diclofenac—ABCC1—mammalian vulva—Crohn's disease	0.000153	0.0128	CbGeAlD
Diclofenac—Nepafenac—PTGS2—Crohn's disease	0.00015	0.102	CrCbGaD
Diclofenac—CYP1A1—epithelium—Crohn's disease	0.000138	0.0116	CbGeAlD
Diclofenac—CYP1A1—skin of body—Crohn's disease	0.000131	0.011	CbGeAlD
Diclofenac—ALOX5—lymph node—Crohn's disease	0.000131	0.011	CbGeAlD
Diclofenac—CYP2C19—digestive system—Crohn's disease	0.000131	0.0109	CbGeAlD
Diclofenac—CYP2B6—skin of body—Crohn's disease	0.000128	0.0107	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—Crohn's disease	0.000123	0.0834	CrCbGaD
Diclofenac—PTGS1—epithelium—Crohn's disease	0.000121	0.0102	CbGeAlD
Diclofenac—CYP1A1—mammalian vulva—Crohn's disease	0.00012	0.01	CbGeAlD
Diclofenac—PTGS1—smooth muscle tissue—Crohn's disease	0.000117	0.00979	CbGeAlD
Diclofenac—PTGS2—epithelium—Crohn's disease	0.000116	0.00971	CbGeAlD
Diclofenac—PTGS1—skin of body—Crohn's disease	0.000115	0.00966	CbGeAlD
Diclofenac—PTGS2—smooth muscle tissue—Crohn's disease	0.000112	0.00936	CbGeAlD
Diclofenac—PTGS2—skin of body—Crohn's disease	0.00011	0.00924	CbGeAlD
Diclofenac—CYP1A2—digestive system—Crohn's disease	0.000107	0.00892	CbGeAlD
Diclofenac—PTGS1—mammalian vulva—Crohn's disease	0.000105	0.00881	CbGeAlD
Diclofenac—CYP1A1—digestive system—Crohn's disease	0.000105	0.0088	CbGeAlD
Diclofenac—CYP2B6—lymphoid tissue—Crohn's disease	0.000103	0.00866	CbGeAlD
Diclofenac—CYP2B6—digestive system—Crohn's disease	0.000102	0.00855	CbGeAlD
Diclofenac—CYP2C9—digestive system—Crohn's disease	0.000101	0.00847	CbGeAlD
Diclofenac—CYP2E1—lymphoid tissue—Crohn's disease	9.71e-05	0.00812	CbGeAlD
Diclofenac—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	9.63e-05	0.00205	CcSEcCtD
Diclofenac—CYP2E1—digestive system—Crohn's disease	9.59e-05	0.00803	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—Crohn's disease	9.59e-05	0.0649	CrCbGaD
Diclofenac—Pancytopenia—Mesalazine—Crohn's disease	9.58e-05	0.00204	CcSEcCtD
Diclofenac—Dysuria—Mesalazine—Crohn's disease	9.43e-05	0.00201	CcSEcCtD
Diclofenac—Viral infection—Prednisone—Crohn's disease	9.42e-05	0.002	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Mesalazine—Crohn's disease	9.37e-05	0.00199	CcSEcCtD
Diclofenac—Arthropathy—Prednisone—Crohn's disease	9.35e-05	0.00199	CcSEcCtD
Diclofenac—Hepatobiliary disease—Azathioprine—Crohn's disease	9.34e-05	0.00199	CcSEcCtD
Diclofenac—Pollakiuria—Mesalazine—Crohn's disease	9.32e-05	0.00198	CcSEcCtD
Diclofenac—ALB—lymph node—Crohn's disease	9.26e-05	0.00775	CbGeAlD
Diclofenac—PTGS1—digestive system—Crohn's disease	9.24e-05	0.00773	CbGeAlD
Diclofenac—Agranulocytosis—Azathioprine—Crohn's disease	9.21e-05	0.00196	CcSEcCtD
Diclofenac—Photosensitivity reaction—Mesalazine—Crohn's disease	9.2e-05	0.00196	CcSEcCtD
Diclofenac—Decreased appetite—Mercaptopurine—Crohn's disease	9.19e-05	0.00195	CcSEcCtD
Diclofenac—Weight increased—Mesalazine—Crohn's disease	9.18e-05	0.00195	CcSEcCtD
Diclofenac—Weight decreased—Mesalazine—Crohn's disease	9.12e-05	0.00194	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	9.12e-05	0.00194	CcSEcCtD
Diclofenac—Pneumonia—Mesalazine—Crohn's disease	9.04e-05	0.00192	CcSEcCtD
Diclofenac—Infestation—Mesalazine—Crohn's disease	8.99e-05	0.00191	CcSEcCtD
Diclofenac—Infestation NOS—Mesalazine—Crohn's disease	8.99e-05	0.00191	CcSEcCtD
Diclofenac—Hypercholesterolaemia—Prednisone—Crohn's disease	8.99e-05	0.00191	CcSEcCtD
Diclofenac—Ulcer—Prednisone—Crohn's disease	8.99e-05	0.00191	CcSEcCtD
Diclofenac—Depression—Mesalazine—Crohn's disease	8.97e-05	0.00191	CcSEcCtD
Diclofenac—ABCC4—lymph node—Crohn's disease	8.96e-05	0.0075	CbGeAlD
Diclofenac—PTGS2—lymphoid tissue—Crohn's disease	8.94e-05	0.00748	CbGeAlD
Diclofenac—Cataract—Prednisone—Crohn's disease	8.93e-05	0.0019	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	8.91e-05	0.0019	CcSEcCtD
Diclofenac—Haemoglobin—Azathioprine—Crohn's disease	8.91e-05	0.00189	CcSEcCtD
Diclofenac—Haemorrhage—Azathioprine—Crohn's disease	8.86e-05	0.00188	CcSEcCtD
Diclofenac—Renal failure—Mesalazine—Crohn's disease	8.84e-05	0.00188	CcSEcCtD
Diclofenac—PTGS2—digestive system—Crohn's disease	8.83e-05	0.00739	CbGeAlD
Diclofenac—Neuropathy peripheral—Mesalazine—Crohn's disease	8.81e-05	0.00187	CcSEcCtD
Diclofenac—Stomatitis—Mesalazine—Crohn's disease	8.76e-05	0.00186	CcSEcCtD
Diclofenac—Jaundice—Mesalazine—Crohn's disease	8.76e-05	0.00186	CcSEcCtD
Diclofenac—Conjunctivitis—Mesalazine—Crohn's disease	8.74e-05	0.00186	CcSEcCtD
Diclofenac—Urinary tract infection—Mesalazine—Crohn's disease	8.74e-05	0.00186	CcSEcCtD
Diclofenac—Vasculitis—Prednisone—Crohn's disease	8.71e-05	0.00185	CcSEcCtD
Diclofenac—Sweating—Mesalazine—Crohn's disease	8.62e-05	0.00183	CcSEcCtD
Diclofenac—Haematuria—Mesalazine—Crohn's disease	8.57e-05	0.00182	CcSEcCtD
Diclofenac—Hepatobiliary disease—Mesalazine—Crohn's disease	8.5e-05	0.00181	CcSEcCtD
Diclofenac—Epistaxis—Mesalazine—Crohn's disease	8.48e-05	0.0018	CcSEcCtD
Diclofenac—Sinusitis—Mesalazine—Crohn's disease	8.44e-05	0.00179	CcSEcCtD
Diclofenac—Agranulocytosis—Mesalazine—Crohn's disease	8.39e-05	0.00178	CcSEcCtD
Diclofenac—Erythema multiforme—Azathioprine—Crohn's disease	8.38e-05	0.00178	CcSEcCtD
Diclofenac—Body temperature increased—Mercaptopurine—Crohn's disease	8.35e-05	0.00178	CcSEcCtD
Diclofenac—Skin exfoliation—Prednisone—Crohn's disease	8.12e-05	0.00173	CcSEcCtD
Diclofenac—Haemoglobin—Mesalazine—Crohn's disease	8.11e-05	0.00173	CcSEcCtD
Diclofenac—Rhinitis—Mesalazine—Crohn's disease	8.09e-05	0.00172	CcSEcCtD
Diclofenac—Fluid retention—Prednisone—Crohn's disease	8.07e-05	0.00172	CcSEcCtD
Diclofenac—Hepatitis—Mesalazine—Crohn's disease	8.07e-05	0.00172	CcSEcCtD
Diclofenac—Haemorrhage—Mesalazine—Crohn's disease	8.07e-05	0.00172	CcSEcCtD
Diclofenac—Pharyngitis—Mesalazine—Crohn's disease	8.01e-05	0.0017	CcSEcCtD
Diclofenac—Immune system disorder—Azathioprine—Crohn's disease	8e-05	0.0017	CcSEcCtD
Diclofenac—Mediastinal disorder—Azathioprine—Crohn's disease	7.99e-05	0.0017	CcSEcCtD
Diclofenac—Urinary tract disorder—Mesalazine—Crohn's disease	7.97e-05	0.0017	CcSEcCtD
Diclofenac—Oedema peripheral—Mesalazine—Crohn's disease	7.95e-05	0.00169	CcSEcCtD
Diclofenac—Chills—Azathioprine—Crohn's disease	7.95e-05	0.00169	CcSEcCtD
Diclofenac—Arrhythmia—Azathioprine—Crohn's disease	7.92e-05	0.00168	CcSEcCtD
Diclofenac—Urethral disorder—Mesalazine—Crohn's disease	7.91e-05	0.00168	CcSEcCtD
Diclofenac—Alopecia—Azathioprine—Crohn's disease	7.83e-05	0.00167	CcSEcCtD
Diclofenac—Hypersensitivity—Mercaptopurine—Crohn's disease	7.78e-05	0.00166	CcSEcCtD
Diclofenac—Oesophagitis—Prednisone—Crohn's disease	7.77e-05	0.00165	CcSEcCtD
Diclofenac—CYP3A4—digestive system—Crohn's disease	7.72e-05	0.00646	CbGeAlD
Diclofenac—Ecchymosis—Prednisone—Crohn's disease	7.69e-05	0.00164	CcSEcCtD
Diclofenac—ABCC1—lymph node—Crohn's disease	7.64e-05	0.0064	CbGeAlD
Diclofenac—Erythema multiforme—Mesalazine—Crohn's disease	7.63e-05	0.00162	CcSEcCtD
Diclofenac—Eye disorder—Mesalazine—Crohn's disease	7.54e-05	0.0016	CcSEcCtD
Diclofenac—Tinnitus—Mesalazine—Crohn's disease	7.53e-05	0.0016	CcSEcCtD
Diclofenac—Cardiac disorder—Mesalazine—Crohn's disease	7.49e-05	0.00159	CcSEcCtD
Diclofenac—Hyperkinesia—Prednisone—Crohn's disease	7.42e-05	0.00158	CcSEcCtD
Diclofenac—Sepsis—Prednisone—Crohn's disease	7.38e-05	0.00157	CcSEcCtD
Diclofenac—Angiopathy—Mesalazine—Crohn's disease	7.32e-05	0.00156	CcSEcCtD
Diclofenac—Immune system disorder—Mesalazine—Crohn's disease	7.29e-05	0.00155	CcSEcCtD
Diclofenac—Mediastinal disorder—Mesalazine—Crohn's disease	7.27e-05	0.00155	CcSEcCtD
Diclofenac—Chills—Mesalazine—Crohn's disease	7.24e-05	0.00154	CcSEcCtD
Diclofenac—Diarrhoea—Mercaptopurine—Crohn's disease	7.23e-05	0.00154	CcSEcCtD
Diclofenac—ABCB1—epithelium—Crohn's disease	7.18e-05	0.00601	CbGeAlD
Diclofenac—Ill-defined disorder—Azathioprine—Crohn's disease	7.16e-05	0.00152	CcSEcCtD
Diclofenac—Alopecia—Mesalazine—Crohn's disease	7.13e-05	0.00152	CcSEcCtD
Diclofenac—Anaemia—Azathioprine—Crohn's disease	7.13e-05	0.00152	CcSEcCtD
Diclofenac—Mental disorder—Mesalazine—Crohn's disease	7.07e-05	0.0015	CcSEcCtD
Diclofenac—Erythema—Mesalazine—Crohn's disease	7.03e-05	0.00149	CcSEcCtD
Diclofenac—Malaise—Azathioprine—Crohn's disease	6.96e-05	0.00148	CcSEcCtD
Diclofenac—Flatulence—Mesalazine—Crohn's disease	6.92e-05	0.00147	CcSEcCtD
Diclofenac—Leukopenia—Azathioprine—Crohn's disease	6.91e-05	0.00147	CcSEcCtD
Diclofenac—Vascular purpura—Prednisone—Crohn's disease	6.9e-05	0.00147	CcSEcCtD
Diclofenac—Tension—Mesalazine—Crohn's disease	6.9e-05	0.00147	CcSEcCtD
Diclofenac—Dysgeusia—Mesalazine—Crohn's disease	6.88e-05	0.00146	CcSEcCtD
Diclofenac—Nervousness—Mesalazine—Crohn's disease	6.82e-05	0.00145	CcSEcCtD
Diclofenac—Cardiac failure congestive—Prednisone—Crohn's disease	6.81e-05	0.00145	CcSEcCtD
Diclofenac—Back pain—Mesalazine—Crohn's disease	6.8e-05	0.00145	CcSEcCtD
Diclofenac—Muscle spasms—Mesalazine—Crohn's disease	6.76e-05	0.00144	CcSEcCtD
Diclofenac—Vomiting—Mercaptopurine—Crohn's disease	6.72e-05	0.00143	CcSEcCtD
Diclofenac—Injury—Prednisone—Crohn's disease	6.72e-05	0.00143	CcSEcCtD
Diclofenac—Rash—Mercaptopurine—Crohn's disease	6.66e-05	0.00142	CcSEcCtD
Diclofenac—Dermatitis—Mercaptopurine—Crohn's disease	6.66e-05	0.00142	CcSEcCtD
Diclofenac—Vision blurred—Mesalazine—Crohn's disease	6.62e-05	0.00141	CcSEcCtD
Diclofenac—Tremor—Mesalazine—Crohn's disease	6.58e-05	0.0014	CcSEcCtD
Diclofenac—Myalgia—Azathioprine—Crohn's disease	6.57e-05	0.0014	CcSEcCtD
Diclofenac—Arthralgia—Azathioprine—Crohn's disease	6.57e-05	0.0014	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	6.52e-05	0.00139	CcSEcCtD
Diclofenac—Ill-defined disorder—Mesalazine—Crohn's disease	6.52e-05	0.00139	CcSEcCtD
Diclofenac—Anaemia—Mesalazine—Crohn's disease	6.49e-05	0.00138	CcSEcCtD
Diclofenac—Discomfort—Azathioprine—Crohn's disease	6.49e-05	0.00138	CcSEcCtD
Diclofenac—Angioedema—Mesalazine—Crohn's disease	6.42e-05	0.00137	CcSEcCtD
Diclofenac—Purpura—Prednisone—Crohn's disease	6.41e-05	0.00136	CcSEcCtD
Diclofenac—Malaise—Mesalazine—Crohn's disease	6.34e-05	0.00135	CcSEcCtD
Diclofenac—Cardiac failure—Prednisone—Crohn's disease	6.33e-05	0.00135	CcSEcCtD
Diclofenac—Vertigo—Mesalazine—Crohn's disease	6.31e-05	0.00134	CcSEcCtD
Diclofenac—Syncope—Mesalazine—Crohn's disease	6.3e-05	0.00134	CcSEcCtD
Diclofenac—Lethargy—Prednisone—Crohn's disease	6.3e-05	0.00134	CcSEcCtD
Diclofenac—Leukopenia—Mesalazine—Crohn's disease	6.29e-05	0.00134	CcSEcCtD
Diclofenac—Nausea—Mercaptopurine—Crohn's disease	6.28e-05	0.00133	CcSEcCtD
Diclofenac—Infection—Azathioprine—Crohn's disease	6.25e-05	0.00133	CcSEcCtD
Diclofenac—ABCB1—mammalian vulva—Crohn's disease	6.23e-05	0.00521	CbGeAlD
Diclofenac—Palpitations—Mesalazine—Crohn's disease	6.21e-05	0.00132	CcSEcCtD
Diclofenac—Loss of consciousness—Mesalazine—Crohn's disease	6.18e-05	0.00131	CcSEcCtD
Diclofenac—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	6.17e-05	0.00131	CcSEcCtD
Diclofenac—Osteoarthritis—Prednisone—Crohn's disease	6.17e-05	0.00131	CcSEcCtD
Diclofenac—Thrombocytopenia—Azathioprine—Crohn's disease	6.16e-05	0.00131	CcSEcCtD
Diclofenac—Cough—Mesalazine—Crohn's disease	6.13e-05	0.0013	CcSEcCtD
Diclofenac—Skin disorder—Azathioprine—Crohn's disease	6.12e-05	0.0013	CcSEcCtD
Diclofenac—Hypertension—Mesalazine—Crohn's disease	6.07e-05	0.00129	CcSEcCtD
Diclofenac—Psychotic disorder—Prednisone—Crohn's disease	6.03e-05	0.00128	CcSEcCtD
Diclofenac—CYP1A1—lymph node—Crohn's disease	6.01e-05	0.00503	CbGeAlD
Diclofenac—Chest pain—Mesalazine—Crohn's disease	5.98e-05	0.00127	CcSEcCtD
Diclofenac—Myalgia—Mesalazine—Crohn's disease	5.98e-05	0.00127	CcSEcCtD
Diclofenac—Arthralgia—Mesalazine—Crohn's disease	5.98e-05	0.00127	CcSEcCtD
Diclofenac—Anxiety—Mesalazine—Crohn's disease	5.96e-05	0.00127	CcSEcCtD
Diclofenac—Face oedema—Prednisone—Crohn's disease	5.96e-05	0.00127	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	5.94e-05	0.00126	CcSEcCtD
Diclofenac—Discomfort—Mesalazine—Crohn's disease	5.91e-05	0.00126	CcSEcCtD
Diclofenac—Irritability—Prednisone—Crohn's disease	5.89e-05	0.00125	CcSEcCtD
Diclofenac—Hypotension—Azathioprine—Crohn's disease	5.88e-05	0.00125	CcSEcCtD
Diclofenac—Dry mouth—Mesalazine—Crohn's disease	5.85e-05	0.00124	CcSEcCtD
Diclofenac—Confusional state—Mesalazine—Crohn's disease	5.78e-05	0.00123	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Azathioprine—Crohn's disease	5.74e-05	0.00122	CcSEcCtD
Diclofenac—Oedema—Mesalazine—Crohn's disease	5.73e-05	0.00122	CcSEcCtD
Diclofenac—Anaphylactic shock—Mesalazine—Crohn's disease	5.73e-05	0.00122	CcSEcCtD
Diclofenac—Infection—Mesalazine—Crohn's disease	5.7e-05	0.00121	CcSEcCtD
Diclofenac—Dry skin—Prednisone—Crohn's disease	5.66e-05	0.0012	CcSEcCtD
Diclofenac—Shock—Mesalazine—Crohn's disease	5.64e-05	0.0012	CcSEcCtD
Diclofenac—Nervous system disorder—Mesalazine—Crohn's disease	5.62e-05	0.0012	CcSEcCtD
Diclofenac—Thrombocytopenia—Mesalazine—Crohn's disease	5.61e-05	0.00119	CcSEcCtD
Diclofenac—Tachycardia—Mesalazine—Crohn's disease	5.6e-05	0.00119	CcSEcCtD
Diclofenac—Skin disorder—Mesalazine—Crohn's disease	5.57e-05	0.00118	CcSEcCtD
Diclofenac—Hyperhidrosis—Mesalazine—Crohn's disease	5.54e-05	0.00118	CcSEcCtD
Diclofenac—ABCB1—lymphoid tissue—Crohn's disease	5.53e-05	0.00463	CbGeAlD
Diclofenac—Anorexia—Mesalazine—Crohn's disease	5.47e-05	0.00116	CcSEcCtD
Diclofenac—ABCB1—digestive system—Crohn's disease	5.46e-05	0.00457	CbGeAlD
Diclofenac—Muscular weakness—Prednisone—Crohn's disease	5.44e-05	0.00116	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Prednisone—Crohn's disease	5.44e-05	0.00116	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Azathioprine—Crohn's disease	5.44e-05	0.00116	CcSEcCtD
Diclofenac—Abdominal distension—Prednisone—Crohn's disease	5.37e-05	0.00114	CcSEcCtD
Diclofenac—Hypotension—Mesalazine—Crohn's disease	5.36e-05	0.00114	CcSEcCtD
Diclofenac—PTGS1—lymph node—Crohn's disease	5.28e-05	0.00442	CbGeAlD
Diclofenac—Pancreatitis—Prednisone—Crohn's disease	5.23e-05	0.00111	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Mesalazine—Crohn's disease	5.22e-05	0.00111	CcSEcCtD
Diclofenac—Sweating increased—Prednisone—Crohn's disease	5.2e-05	0.00111	CcSEcCtD
Diclofenac—Feeling abnormal—Azathioprine—Crohn's disease	5.19e-05	0.0011	CcSEcCtD
Diclofenac—Insomnia—Mesalazine—Crohn's disease	5.19e-05	0.0011	CcSEcCtD
Diclofenac—Paraesthesia—Mesalazine—Crohn's disease	5.15e-05	0.0011	CcSEcCtD
Diclofenac—Gastrointestinal pain—Azathioprine—Crohn's disease	5.15e-05	0.00109	CcSEcCtD
Diclofenac—Dyspnoea—Mesalazine—Crohn's disease	5.11e-05	0.00109	CcSEcCtD
Diclofenac—Somnolence—Mesalazine—Crohn's disease	5.1e-05	0.00108	CcSEcCtD
Diclofenac—Dyspepsia—Mesalazine—Crohn's disease	5.05e-05	0.00107	CcSEcCtD
Diclofenac—PTGS2—lymph node—Crohn's disease	5.04e-05	0.00422	CbGeAlD
Diclofenac—Decreased appetite—Mesalazine—Crohn's disease	4.99e-05	0.00106	CcSEcCtD
Diclofenac—Body temperature increased—Azathioprine—Crohn's disease	4.98e-05	0.00106	CcSEcCtD
Diclofenac—Abdominal pain—Azathioprine—Crohn's disease	4.98e-05	0.00106	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Mesalazine—Crohn's disease	4.95e-05	0.00105	CcSEcCtD
Diclofenac—Fatigue—Mesalazine—Crohn's disease	4.94e-05	0.00105	CcSEcCtD
Diclofenac—Erectile dysfunction—Prednisone—Crohn's disease	4.91e-05	0.00105	CcSEcCtD
Diclofenac—Pain—Mesalazine—Crohn's disease	4.9e-05	0.00104	CcSEcCtD
Diclofenac—Constipation—Mesalazine—Crohn's disease	4.9e-05	0.00104	CcSEcCtD
Diclofenac—Weight increased—Prednisone—Crohn's disease	4.86e-05	0.00103	CcSEcCtD
Diclofenac—Weight decreased—Prednisone—Crohn's disease	4.83e-05	0.00103	CcSEcCtD
Diclofenac—Hyperglycaemia—Prednisone—Crohn's disease	4.81e-05	0.00102	CcSEcCtD
Diclofenac—Depression—Prednisone—Crohn's disease	4.74e-05	0.00101	CcSEcCtD
Diclofenac—Feeling abnormal—Mesalazine—Crohn's disease	4.73e-05	0.00101	CcSEcCtD
Diclofenac—Acute coronary syndrome—Prednisone—Crohn's disease	4.69e-05	0.000997	CcSEcCtD
Diclofenac—Gastrointestinal pain—Mesalazine—Crohn's disease	4.69e-05	0.000997	CcSEcCtD
Diclofenac—Neuropathy peripheral—Prednisone—Crohn's disease	4.66e-05	0.000992	CcSEcCtD
Diclofenac—Myocardial infarction—Prednisone—Crohn's disease	4.66e-05	0.000992	CcSEcCtD
Diclofenac—Hypersensitivity—Azathioprine—Crohn's disease	4.64e-05	0.000986	CcSEcCtD
Diclofenac—Urticaria—Mesalazine—Crohn's disease	4.56e-05	0.000969	CcSEcCtD
Diclofenac—Abdominal pain—Mesalazine—Crohn's disease	4.53e-05	0.000964	CcSEcCtD
Diclofenac—Body temperature increased—Mesalazine—Crohn's disease	4.53e-05	0.000964	CcSEcCtD
Diclofenac—Bradycardia—Prednisone—Crohn's disease	4.35e-05	0.000925	CcSEcCtD
Diclofenac—Diarrhoea—Azathioprine—Crohn's disease	4.31e-05	0.000916	CcSEcCtD
Diclofenac—Haemoglobin—Prednisone—Crohn's disease	4.29e-05	0.000913	CcSEcCtD
Diclofenac—Haemorrhage—Prednisone—Crohn's disease	4.27e-05	0.000908	CcSEcCtD
Diclofenac—Hallucination—Prednisone—Crohn's disease	4.25e-05	0.000904	CcSEcCtD
Diclofenac—Hypersensitivity—Mesalazine—Crohn's disease	4.23e-05	0.000899	CcSEcCtD
Diclofenac—Dizziness—Azathioprine—Crohn's disease	4.16e-05	0.000885	CcSEcCtD
Diclofenac—Asthenia—Mesalazine—Crohn's disease	4.11e-05	0.000875	CcSEcCtD
Diclofenac—Pruritus—Mesalazine—Crohn's disease	4.06e-05	0.000863	CcSEcCtD
Diclofenac—Vomiting—Azathioprine—Crohn's disease	4e-05	0.000851	CcSEcCtD
Diclofenac—Eye disorder—Prednisone—Crohn's disease	3.99e-05	0.000849	CcSEcCtD
Diclofenac—Rash—Azathioprine—Crohn's disease	3.97e-05	0.000844	CcSEcCtD
Diclofenac—Dermatitis—Azathioprine—Crohn's disease	3.97e-05	0.000843	CcSEcCtD
Diclofenac—Flushing—Prednisone—Crohn's disease	3.96e-05	0.000843	CcSEcCtD
Diclofenac—Headache—Azathioprine—Crohn's disease	3.94e-05	0.000839	CcSEcCtD
Diclofenac—Diarrhoea—Mesalazine—Crohn's disease	3.92e-05	0.000834	CcSEcCtD
Diclofenac—Angiopathy—Prednisone—Crohn's disease	3.87e-05	0.000824	CcSEcCtD
Diclofenac—Immune system disorder—Prednisone—Crohn's disease	3.86e-05	0.00082	CcSEcCtD
Diclofenac—Arrhythmia—Prednisone—Crohn's disease	3.82e-05	0.000811	CcSEcCtD
Diclofenac—Dizziness—Mesalazine—Crohn's disease	3.79e-05	0.000806	CcSEcCtD
Diclofenac—Alopecia—Prednisone—Crohn's disease	3.77e-05	0.000803	CcSEcCtD
Diclofenac—Mental disorder—Prednisone—Crohn's disease	3.74e-05	0.000796	CcSEcCtD
Diclofenac—Nausea—Azathioprine—Crohn's disease	3.74e-05	0.000795	CcSEcCtD
Diclofenac—Malnutrition—Prednisone—Crohn's disease	3.72e-05	0.000791	CcSEcCtD
Diclofenac—Erythema—Prednisone—Crohn's disease	3.72e-05	0.000791	CcSEcCtD
Diclofenac—Vomiting—Mesalazine—Crohn's disease	3.65e-05	0.000775	CcSEcCtD
Diclofenac—Rash—Mesalazine—Crohn's disease	3.62e-05	0.000769	CcSEcCtD
Diclofenac—Dermatitis—Mesalazine—Crohn's disease	3.61e-05	0.000768	CcSEcCtD
Diclofenac—Headache—Mesalazine—Crohn's disease	3.59e-05	0.000764	CcSEcCtD
Diclofenac—Vision blurred—Prednisone—Crohn's disease	3.5e-05	0.000745	CcSEcCtD
Diclofenac—Ill-defined disorder—Prednisone—Crohn's disease	3.45e-05	0.000734	CcSEcCtD
Diclofenac—Anaemia—Prednisone—Crohn's disease	3.44e-05	0.000731	CcSEcCtD
Diclofenac—Agitation—Prednisone—Crohn's disease	3.42e-05	0.000727	CcSEcCtD
Diclofenac—Nausea—Mesalazine—Crohn's disease	3.41e-05	0.000724	CcSEcCtD
Diclofenac—Angioedema—Prednisone—Crohn's disease	3.4e-05	0.000722	CcSEcCtD
Diclofenac—Malaise—Prednisone—Crohn's disease	3.35e-05	0.000713	CcSEcCtD
Diclofenac—Vertigo—Prednisone—Crohn's disease	3.34e-05	0.00071	CcSEcCtD
Diclofenac—Syncope—Prednisone—Crohn's disease	3.33e-05	0.000709	CcSEcCtD
Diclofenac—Loss of consciousness—Prednisone—Crohn's disease	3.27e-05	0.000695	CcSEcCtD
Diclofenac—Convulsion—Prednisone—Crohn's disease	3.22e-05	0.000685	CcSEcCtD
Diclofenac—Hypertension—Prednisone—Crohn's disease	3.21e-05	0.000683	CcSEcCtD
Diclofenac—Myalgia—Prednisone—Crohn's disease	3.17e-05	0.000673	CcSEcCtD
Diclofenac—Arthralgia—Prednisone—Crohn's disease	3.17e-05	0.000673	CcSEcCtD
Diclofenac—Anxiety—Prednisone—Crohn's disease	3.15e-05	0.000671	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	3.14e-05	0.000668	CcSEcCtD
Diclofenac—Discomfort—Prednisone—Crohn's disease	3.13e-05	0.000665	CcSEcCtD
Diclofenac—ABCB1—lymph node—Crohn's disease	3.12e-05	0.00261	CbGeAlD
Diclofenac—Anaphylactic shock—Prednisone—Crohn's disease	3.03e-05	0.000645	CcSEcCtD
Diclofenac—Oedema—Prednisone—Crohn's disease	3.03e-05	0.000645	CcSEcCtD
Diclofenac—Infection—Prednisone—Crohn's disease	3.01e-05	0.000641	CcSEcCtD
Diclofenac—Shock—Prednisone—Crohn's disease	2.99e-05	0.000635	CcSEcCtD
Diclofenac—Nervous system disorder—Prednisone—Crohn's disease	2.98e-05	0.000633	CcSEcCtD
Diclofenac—Tachycardia—Prednisone—Crohn's disease	2.96e-05	0.00063	CcSEcCtD
Diclofenac—Skin disorder—Prednisone—Crohn's disease	2.95e-05	0.000627	CcSEcCtD
Diclofenac—Hyperhidrosis—Prednisone—Crohn's disease	2.93e-05	0.000624	CcSEcCtD
Diclofenac—Anorexia—Prednisone—Crohn's disease	2.89e-05	0.000615	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Prednisone—Crohn's disease	2.76e-05	0.000588	CcSEcCtD
Diclofenac—Insomnia—Prednisone—Crohn's disease	2.74e-05	0.000584	CcSEcCtD
Diclofenac—Paraesthesia—Prednisone—Crohn's disease	2.72e-05	0.000579	CcSEcCtD
Diclofenac—Dyspepsia—Prednisone—Crohn's disease	2.67e-05	0.000568	CcSEcCtD
Diclofenac—Decreased appetite—Prednisone—Crohn's disease	2.64e-05	0.000561	CcSEcCtD
Diclofenac—Fatigue—Prednisone—Crohn's disease	2.62e-05	0.000556	CcSEcCtD
Diclofenac—Constipation—Prednisone—Crohn's disease	2.59e-05	0.000552	CcSEcCtD
Diclofenac—Feeling abnormal—Prednisone—Crohn's disease	2.5e-05	0.000532	CcSEcCtD
Diclofenac—Gastrointestinal pain—Prednisone—Crohn's disease	2.48e-05	0.000528	CcSEcCtD
Diclofenac—Urticaria—Prednisone—Crohn's disease	2.41e-05	0.000513	CcSEcCtD
Diclofenac—Body temperature increased—Prednisone—Crohn's disease	2.4e-05	0.00051	CcSEcCtD
Diclofenac—Abdominal pain—Prednisone—Crohn's disease	2.4e-05	0.00051	CcSEcCtD
Diclofenac—Hypersensitivity—Prednisone—Crohn's disease	2.24e-05	0.000475	CcSEcCtD
Diclofenac—Asthenia—Prednisone—Crohn's disease	2.18e-05	0.000463	CcSEcCtD
Diclofenac—Pruritus—Prednisone—Crohn's disease	2.15e-05	0.000457	CcSEcCtD
Diclofenac—Diarrhoea—Prednisone—Crohn's disease	2.08e-05	0.000442	CcSEcCtD
Diclofenac—Dizziness—Prednisone—Crohn's disease	2.01e-05	0.000427	CcSEcCtD
Diclofenac—Vomiting—Prednisone—Crohn's disease	1.93e-05	0.00041	CcSEcCtD
Diclofenac—Rash—Prednisone—Crohn's disease	1.91e-05	0.000407	CcSEcCtD
Diclofenac—Dermatitis—Prednisone—Crohn's disease	1.91e-05	0.000406	CcSEcCtD
Diclofenac—Headache—Prednisone—Crohn's disease	1.9e-05	0.000404	CcSEcCtD
Diclofenac—Nausea—Prednisone—Crohn's disease	1.8e-05	0.000383	CcSEcCtD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.98e-06	0.000244	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—IL1B—Crohn's disease	8.94e-06	0.000243	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—TNF—Crohn's disease	8.82e-06	0.00024	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—TNF—Crohn's disease	8.82e-06	0.00024	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GPX4—Crohn's disease	8.8e-06	0.000239	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—RASGRP1—Crohn's disease	8.78e-06	0.000239	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GCKR—Crohn's disease	8.74e-06	0.000238	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—IL2RA—Crohn's disease	8.67e-06	0.000236	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—CXCL8—Crohn's disease	8.64e-06	0.000235	CbGpPWpGaD
Diclofenac—TTR—Disease—SMAD3—Crohn's disease	8.63e-06	0.000235	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TNF—Crohn's disease	8.55e-06	0.000233	CbGpPWpGaD
Diclofenac—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	8.53e-06	0.000232	CbGpPWpGaD
Diclofenac—CXCL8—Cellular Senescence—IL6—Crohn's disease	8.5e-06	0.000231	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GCKR—Crohn's disease	8.5e-06	0.000231	CbGpPWpGaD
Diclofenac—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	8.48e-06	0.000231	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.45e-06	0.00023	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—UBE2D1—Crohn's disease	8.45e-06	0.00023	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	8.41e-06	0.000229	CbGpPWpGaD
Diclofenac—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	8.4e-06	0.000229	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IL2RA—Crohn's disease	8.32e-06	0.000226	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—RIPK2—Crohn's disease	8.2e-06	0.000223	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	8.12e-06	0.000221	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.06e-06	0.000219	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.06e-06	0.000219	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL3—Crohn's disease	7.99e-06	0.000218	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—MTMR3—Crohn's disease	7.99e-06	0.000217	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	7.98e-06	0.000217	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	7.98e-06	0.000217	CbGpPWpGaD
Diclofenac—ABCC1—Disease—GCKR—Crohn's disease	7.95e-06	0.000216	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RSPO3—Crohn's disease	7.79e-06	0.000212	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—RASGRP1—Crohn's disease	7.73e-06	0.00021	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—STAT3—Crohn's disease	7.72e-06	0.00021	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.72e-06	0.00021	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—FADS1—Crohn's disease	7.64e-06	0.000208	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	7.62e-06	0.000207	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—IL6—Crohn's disease	7.56e-06	0.000206	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.55e-06	0.000205	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PLA2G4F—Crohn's disease	7.46e-06	0.000203	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	7.42e-06	0.000202	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SEL1L—Crohn's disease	7.38e-06	0.000201	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—FADS1—Crohn's disease	7.36e-06	0.0002	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.35e-06	0.0002	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	7.17e-06	0.000195	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GPX4—Crohn's disease	7.15e-06	0.000195	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCR6—Crohn's disease	7.15e-06	0.000195	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—IL6—Crohn's disease	7.12e-06	0.000194	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—IL6—Crohn's disease	7.12e-06	0.000194	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SLC11A1—Crohn's disease	7.03e-06	0.000191	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	7.02e-06	0.000191	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SOCS1—Crohn's disease	7e-06	0.000191	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—IL2RA—Crohn's disease	7e-06	0.000191	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GCKR—Crohn's disease	6.91e-06	0.000188	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—IL6—Crohn's disease	6.9e-06	0.000188	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GPX4—Crohn's disease	6.89e-06	0.000188	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.88e-06	0.000187	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.82e-06	0.000186	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	6.79e-06	0.000185	CbGpPWpGaD
Diclofenac—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	6.78e-06	0.000184	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.76e-06	0.000184	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—TNF—Crohn's disease	6.68e-06	0.000182	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GCKR—Crohn's disease	6.66e-06	0.000181	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	6.64e-06	0.000181	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	6.62e-06	0.00018	CbGpPWpGaD
Diclofenac—PTGS2—Disease—LTF—Crohn's disease	6.62e-06	0.00018	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—TNF—Crohn's disease	6.49e-06	0.000177	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RBX1—Crohn's disease	6.46e-06	0.000176	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—IL6—Crohn's disease	6.42e-06	0.000175	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL2RA—Crohn's disease	6.36e-06	0.000173	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—MTMR3—Crohn's disease	6.34e-06	0.000173	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTGER4—Crohn's disease	6.29e-06	0.000171	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.28e-06	0.000171	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—ALB—Crohn's disease	6.27e-06	0.000171	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—FADS1—Crohn's disease	6.22e-06	0.000169	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—MTMR3—Crohn's disease	6.1e-06	0.000166	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	6.07e-06	0.000165	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SMAD3—Crohn's disease	6.05e-06	0.000165	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PLA2G4F—Crohn's disease	6.03e-06	0.000164	CbGpPWpGaD
Diclofenac—ABCC1—Disease—RBX1—Crohn's disease	6.03e-06	0.000164	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HSPA1B—Crohn's disease	6.03e-06	0.000164	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.98e-06	0.000163	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—MTMR3—Crohn's disease	5.97e-06	0.000163	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.88e-06	0.00016	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TYK2—Crohn's disease	5.86e-06	0.00016	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—JAK2—Crohn's disease	5.83e-06	0.000159	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GPX4—Crohn's disease	5.83e-06	0.000159	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—ITGA4—Crohn's disease	5.75e-06	0.000156	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—UBE2D1—Crohn's disease	5.67e-06	0.000154	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	5.66e-06	0.000154	CbGpPWpGaD
Diclofenac—TTR—Disease—TYK2—Crohn's disease	5.63e-06	0.000153	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—ALB—Crohn's disease	5.63e-06	0.000153	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—MTMR3—Crohn's disease	5.63e-06	0.000153	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GCKR—Crohn's disease	5.63e-06	0.000153	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—IL3—Crohn's disease	5.6e-06	0.000153	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL2RA—Crohn's disease	5.6e-06	0.000152	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—JAK2—Crohn's disease	5.59e-06	0.000152	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RIPK2—Crohn's disease	5.5e-06	0.00015	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	5.48e-06	0.000149	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	5.43e-06	0.000148	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—RASGRP1—Crohn's disease	5.42e-06	0.000148	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	5.42e-06	0.000147	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—IL6—Crohn's disease	5.39e-06	0.000147	CbGpPWpGaD
Diclofenac—TTR—Disease—JAK2—Crohn's disease	5.37e-06	0.000146	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL3—Crohn's disease	5.36e-06	0.000146	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	5.36e-06	0.000146	CbGpPWpGaD
Diclofenac—PTGS2—Disease—GCKR—Crohn's disease	5.34e-06	0.000145	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PLA2G4F—Crohn's disease	5.29e-06	0.000144	CbGpPWpGaD
Diclofenac—ABCC1—Disease—UBE2D1—Crohn's disease	5.28e-06	0.000144	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RASGRP1—Crohn's disease	5.18e-06	0.000141	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTMR3—Crohn's disease	5.16e-06	0.00014	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTMR3—Crohn's disease	5.13e-06	0.00014	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	5.12e-06	0.000139	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—CXCL8—Crohn's disease	5.1e-06	0.000139	CbGpPWpGaD
Diclofenac—TTR—Disease—CD4—Crohn's disease	5.09e-06	0.000139	CbGpPWpGaD
Diclofenac—TTR—Disease—PTGS2—Crohn's disease	5.06e-06	0.000138	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—FADS1—Crohn's disease	4.94e-06	0.000134	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	4.94e-06	0.000134	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PTGS2—Crohn's disease	4.92e-06	0.000134	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—IL6—Crohn's disease	4.85e-06	0.000132	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.76e-06	0.00013	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—FADS1—Crohn's disease	4.75e-06	0.000129	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	4.74e-06	0.000129	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	4.73e-06	0.000129	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SLC11A1—Crohn's disease	4.72e-06	0.000128	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—JAK2—Crohn's disease	4.7e-06	0.000128	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SOCS1—Crohn's disease	4.7e-06	0.000128	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—FADS1—Crohn's disease	4.65e-06	0.000127	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GPX4—Crohn's disease	4.63e-06	0.000126	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTMR3—Crohn's disease	4.61e-06	0.000125	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	4.52e-06	0.000123	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.52e-06	0.000123	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTMR3—Crohn's disease	4.5e-06	0.000122	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—TYK2—Crohn's disease	4.48e-06	0.000122	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GCKR—Crohn's disease	4.47e-06	0.000122	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GPX4—Crohn's disease	4.45e-06	0.000121	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—FADS1—Crohn's disease	4.39e-06	0.000119	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GPX4—Crohn's disease	4.36e-06	0.000119	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GCKR—Crohn's disease	4.29e-06	0.000117	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—JAK2—Crohn's disease	4.27e-06	0.000116	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	4.22e-06	0.000115	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GCKR—Crohn's disease	4.21e-06	0.000115	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTMR3—Crohn's disease	4.2e-06	0.000114	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.16e-06	0.000113	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—ALB—Crohn's disease	4.13e-06	0.000112	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GPX4—Crohn's disease	4.11e-06	0.000112	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—STAT3—Crohn's disease	4.1e-06	0.000112	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SMAD3—Crohn's disease	4.06e-06	0.00011	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RBX1—Crohn's disease	4.04e-06	0.00011	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HSPA1B—Crohn's disease	4.04e-06	0.00011	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.02e-06	0.000109	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—FADS1—Crohn's disease	4.02e-06	0.000109	CbGpPWpGaD
Diclofenac—ALB—Metabolism—FADS1—Crohn's disease	4e-06	0.000109	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GCKR—Crohn's disease	3.97e-06	0.000108	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TYK2—Crohn's disease	3.94e-06	0.000107	CbGpPWpGaD
Diclofenac—TTR—Disease—STAT3—Crohn's disease	3.94e-06	0.000107	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—IL2RA—Crohn's disease	3.93e-06	0.000107	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SMAD3—Crohn's disease	3.78e-06	0.000103	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GPX4—Crohn's disease	3.76e-06	0.000102	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—JAK2—Crohn's disease	3.76e-06	0.000102	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL2RA—Crohn's disease	3.75e-06	0.000102	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GPX4—Crohn's disease	3.74e-06	0.000102	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GCKR—Crohn's disease	3.64e-06	9.9e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GCKR—Crohn's disease	3.62e-06	9.84e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PTGS2—Crohn's disease	3.61e-06	9.84e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTMR3—Crohn's disease	3.59e-06	9.77e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—FADS1—Crohn's disease	3.59e-06	9.77e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—UBE2D1—Crohn's disease	3.55e-06	9.65e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.52e-06	9.58e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—FADS1—Crohn's disease	3.5e-06	9.53e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CXCL8—Crohn's disease	3.43e-06	9.35e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GPX4—Crohn's disease	3.36e-06	9.15e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GPX4—Crohn's disease	3.28e-06	8.93e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—FADS1—Crohn's disease	3.27e-06	8.91e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	3.26e-06	8.87e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GCKR—Crohn's disease	3.25e-06	8.83e-05	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.2e-06	8.72e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.19e-06	8.69e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GCKR—Crohn's disease	3.17e-06	8.62e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GPX4—Crohn's disease	3.06e-06	8.34e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GCKR—Crohn's disease	2.96e-06	8.05e-05	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IL6—Crohn's disease	2.87e-06	7.8e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.83e-06	7.71e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—FADS1—Crohn's disease	2.8e-06	7.61e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ALB—Crohn's disease	2.78e-06	7.57e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.77e-06	7.54e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—STAT3—Crohn's disease	2.76e-06	7.52e-05	CbGpPWpGaD
Diclofenac—TTR—Disease—IL6—Crohn's disease	2.75e-06	7.5e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ALB—Crohn's disease	2.7e-06	7.36e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TYK2—Crohn's disease	2.65e-06	7.2e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—JAK2—Crohn's disease	2.64e-06	7.18e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GPX4—Crohn's disease	2.62e-06	7.13e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.6e-06	7.07e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SMAD3—Crohn's disease	2.54e-06	6.9e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GCKR—Crohn's disease	2.53e-06	6.88e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—JAK2—Crohn's disease	2.52e-06	6.87e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.48e-06	6.75e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TYK2—Crohn's disease	2.47e-06	6.71e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTGS2—Crohn's disease	2.43e-06	6.62e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTGS2—Crohn's disease	2.37e-06	6.44e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—JAK2—Crohn's disease	2.35e-06	6.4e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.32e-06	6.31e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.27e-06	6.19e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.26e-06	6.15e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CD4—Crohn's disease	2.23e-06	6.07e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—Crohn's disease	2.21e-06	6.03e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ALB—Crohn's disease	2.2e-06	5.98e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL6—Crohn's disease	2.19e-06	5.96e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—FADS1—Crohn's disease	2.16e-06	5.87e-05	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.15e-06	5.86e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ALB—Crohn's disease	2.12e-06	5.77e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.11e-06	5.76e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.03e-06	5.52e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GPX4—Crohn's disease	2.02e-06	5.5e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GCKR—Crohn's disease	1.95e-06	5.31e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—Crohn's disease	1.93e-06	5.25e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—Crohn's disease	1.92e-06	5.23e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—Crohn's disease	1.85e-06	5.05e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—Crohn's disease	1.85e-06	5.04e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.85e-06	5.04e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.81e-06	4.92e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ALB—Crohn's disease	1.79e-06	4.88e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—Crohn's disease	1.73e-06	4.7e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TYK2—Crohn's disease	1.65e-06	4.5e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.58e-06	4.3e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—JAK2—Crohn's disease	1.58e-06	4.3e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—Crohn's disease	1.57e-06	4.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD4—Crohn's disease	1.5e-06	4.07e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—Crohn's disease	1.42e-06	3.87e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—Crohn's disease	1.37e-06	3.72e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—Crohn's disease	1.34e-06	3.64e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—Crohn's disease	1.29e-06	3.52e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—Crohn's disease	1.26e-06	3.44e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—Crohn's disease	1.21e-06	3.28e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—Crohn's disease	1.2e-06	3.26e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—Crohn's disease	1.17e-06	3.19e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—Crohn's disease	1.16e-06	3.15e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—Crohn's disease	1.16e-06	3.15e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—Crohn's disease	1.1e-06	3.01e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—Crohn's disease	1.03e-06	2.81e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.01e-06	2.76e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—Crohn's disease	1.01e-06	2.74e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—Crohn's disease	1.01e-06	2.74e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—Crohn's disease	9.42e-07	2.56e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—Crohn's disease	9.04e-07	2.46e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—Crohn's disease	8.82e-07	2.4e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—Crohn's disease	8.24e-07	2.24e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—Crohn's disease	8.09e-07	2.2e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—Crohn's disease	8.05e-07	2.19e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—Crohn's disease	7.04e-07	1.92e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—Crohn's disease	6.21e-07	1.69e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—Crohn's disease	5.43e-07	1.48e-05	CbGpPWpGaD
